Healthtech Oncology

Healthtech Oncology is a medical technology company focused on developing innovative therapeutic solutions for the treatment of solid tumors. The company's core technology utilizes Irreversible Electroporation (IRE), a non-thermal ablation technique that uses short-duration, high-voltage electrical pulses to create permanent nanopores in cancer cell membranes, leading to programmed cell death. This approach is designed to treat tumors in sensitive areas where traditional surgery or thermal ablation might damage critical structures like nerves or blood vessels. Healthtech Oncology is currently advancing its platform through clinical trials targeting difficult-to-treat cancers such as glioblastoma and pancreatic adenocarcinoma.